W, G., J, L., N, Y., S, Z., T, Z., Q, L., . . . S, F. (2026). Multidrug-resistant Acinetobacter spp. bloodstream infections in hematologic patients: Clinical characteristics, genomic features, and eravacycline-based combination therapy. BMC infectious diseases, 26(1), . https://doi.org/10.1186/s12879-026-13653-4
Chicago Style (17th ed.) CitationW, Guo, et al. "Multidrug-resistant Acinetobacter Spp. Bloodstream Infections in Hematologic Patients: Clinical Characteristics, Genomic Features, and Eravacycline-based Combination Therapy." BMC Infectious Diseases 26, no. 1 (2026). https://doi.org/10.1186/s12879-026-13653-4.
MLA (9th ed.) CitationW, Guo, et al. "Multidrug-resistant Acinetobacter Spp. Bloodstream Infections in Hematologic Patients: Clinical Characteristics, Genomic Features, and Eravacycline-based Combination Therapy." BMC Infectious Diseases, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12879-026-13653-4.